Biosimilar Committee Roster Shows More Focus On Analytics For Inflectra
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA adds experts in protein engineering and physicochemical characterization to second biosimilar advisory committee after concerns there was too much clinical discussion at first meeting.
You may also be interested in...
Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Biden COVID-19 Plan Would Grow Domestic Manufacturing Base
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Biden Vaccination Plan Would Grow Domestic Manufacturing Base
Proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: